Voyager Therapeutics, Inc. (VYGR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 230.66M |
| Enterprise Value | 201.86M |
| P/E Ratio | -1.01 |
| PEG Ratio | 0.57 |
| Price/Sales Ratio | 3.27 |
| Price/Book Ratio | 0.72 |
| Enterprise/Revenue | 3.18 |
| Enterprise/EBITDA | -1.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -3.13 |
| Operating Margin | -3.4 |
AD
Management Effectiveness
| Return On Assets | -0.54 |
| Return On Equity | -0.58 |
Income Statement
| Revenue | 40.37M |
| Revenue/Share | 0.57 |
| Gross Profit | -91.9M |
| EBITDA | -115.52M |
| Net Income | -119.72M |
| Diluted EPS | -2.04 |
Balance Sheet
| Total Cash | 116.34M |
| Total Cash/Share | 1.92 |
| Total Debt | 32.57M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 7.51 |
| Book Value Per Share | 2.55 |
Price History
| 52-Week Change | -61.84 |
| 52-Week High | 5.48 |
| 52-Week Low | 1.82 |
| Moving Average 50 Days | 2.92 |
| Moving Average 200 Days | 3.54 |
Statistics
| Average Volume | 604,437 |
| Shares Outstanding | 61.62M |
| % Held by Institutions | 58.15 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
